EUVIMEDEUVIMED entdecken
Kohortenstudie

Disparate Kinetics of Viable Virus Shedding in Immunocompromised Patients: SARS-CoV-2 Versus Influenza Virus—A Prospective Real-World Cohort Study

So Yun Lim, Jungmin Lee, Ji-Soo Kwon iD, Euijin Chang iD, Joo-Yeon Lee iD, Man-Seong Park, Sung-Han Kim iD

The Journal of Infectious Diseases · 2025

DOI: 10.1093/infdis/jiaf479 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift The Journal of Infectious Diseases, 2025. Verfasst von So Yun Lim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Virus Shedding, Immunocompromised Host, COVID-19, SARS-CoV-2. Die Arbeit nennt 12 Literaturangaben. Gefördert von: National Research Foundation of Korea, Ministry of Science, ICT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There are limited data comparing viral shedding between influenza and SARS-CoV-2 in immunocompromised patients. We prospectively enrolled 70 SARS-CoV-2 and 16 influenza patients, with 48 SARS-CoV-2 patients matched to 16 influenza patients by propensity score. Weekly collected respiratory samples were subjected to viral culture and antigen testing. In matched cohorts, the time to culture-confirmed viral clearance was shorter for influenza than SARS-CoV-2 (median, 4.5 vs. 29 days; adjusted hazard ratio [aHR] 27.5; P < .001), and antigen negativity occurred faster (3 vs. 23 days; aHR 19.2; P < .001). These findings show different clearance kinetics for influenza and SARS-CoV-2 in immunocompromised patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Virus SheddingImmunocompromised HostCOVID-19SARS-CoV-2Influenza, HumanOrthomyxoviridaeHumansFemaleMaleProspective StudiesMiddle AgedAgedAdult

Stichwörter der Autor:innen

SARS-CoV-2immunoassayinfluenzaviral sheddingvirus culture

Autor:innen und Institutionen

  • Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Department of Microbiology, Vaccine Innovation Center, and Institute for Viral Diseases, Korea University College of Medicine, Seoul, Republic of Korea.
  • Center for Emerging Virus Research, National Institute of Infectious Diseases, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea.

ORCID-Profile: Ji-Soo Kwon, Euijin Chang, Joo-Yeon Lee, Sung-Han Kim

Förderung

  • National Research Foundation of Korea
  • Ministry of Science
  • ICT

Zitieren

APA

Lim, S. Y., Lee, J., Kwon, J. S., Chang, E., Lee, J. Y., Park, M. S., & Kim, S. H. (2025). Disparate Kinetics of Viable Virus Shedding in Immunocompromised Patients: SARS-CoV-2 Versus Influenza Virus—A Prospective Real-World Cohort Study. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiaf479

Vancouver

Lim SY, Lee J, Kwon JS, Chang E, Lee JY, Park MS, et al. Disparate Kinetics of Viable Virus Shedding in Immunocompromised Patients: SARS-CoV-2 Versus Influenza Virus—A Prospective Real-World Cohort Study. The Journal of Infectious Diseases. 2025. doi:10.1093/infdis/jiaf479

BibTeX
@article{Lim2025,
  author = {Lim, So Yun and Lee, Jungmin and Kwon, Ji-Soo and Chang, Euijin and Lee, Joo-Yeon and Park, Man-Seong and Kim, Sung-Han},
  title = {Disparate Kinetics of Viable Virus Shedding in Immunocompromised Patients: SARS-CoV-2 Versus Influenza Virus—A Prospective Real-World Cohort Study},
  journal = {The Journal of Infectious Diseases},
  year = {2025},
  doi = {10.1093/infdis/jiaf479}
}
Kostenlos starten →